• Medicus Pharma will execute a 50-for-1 share consolidation effective Oct. 12, 2026.
• Nasdaq trading on a consolidated basis expected to start at the open on Oct. 12 under ticker MDCX.
• Move targets a higher bid price to regain compliance with Nasdaq’s minimum bid requirement.
• New CUSIP 58471K301 issued for the post-consolidation common shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medicus Pharma Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001062993-26-005226), on October 07, 2026, and is solely responsible for the information contained therein.